BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8456907)

  • 1. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: prediction of response and recurrence.
    Rose PG; Baker S; Fournier L; Nelson BE; Hunter RE
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):942-6. PubMed ID: 8456907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM; Vahrson HW; Freeman DA
    Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix.
    de Bruijn HW; Duk JM; van der Zee AG; Pras E; Willemse PH; Boonstra H; Hollema H; Mourits MJ; de Vries EG; Aalders JG
    Tumour Biol; 1998; 19(6):505-16. PubMed ID: 9817980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum squamous cell carcinoma antigen in gynecologic malignancies with special reference to cervical cancer.
    Hsieh CY; Chang DY; Huang SC; Yen ML; Juang GT; Ouyang PC
    Taiwan Yi Xue Hui Za Zhi; 1989 Aug; 88(8):797-800. PubMed ID: 2592943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
    Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: is it cost-effective?
    Chan YM; Ng TY; Ngan HY; Wong LC
    Gynecol Oncol; 2002 Jan; 84(1):7-11. PubMed ID: 11748969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer.
    Scambia G; Benedetti Panici P; Foti E; Amoroso M; Salerno G; Ferrandina G; Battaglia F; Greggi S; De Gaetano A; Puglia G
    J Clin Oncol; 1994 Nov; 12(11):2309-16. PubMed ID: 7964945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma antigen in patients with cancer of the uterine cervix.
    Fuith LC; Daxenbichler G
    Gynecol Obstet Invest; 1988; 26(1):77-82. PubMed ID: 3169633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer.
    Esajas MD; Duk JM; de Bruijn HW; Aalders JG; Willemse PH; Sluiter W; Pras B; ten Hoor K; Hollema H; van der Zee AG
    J Clin Oncol; 2001 Oct; 19(19):3960-6. PubMed ID: 11579117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH; Lee SW; Yu M; Jeong S; Lee JW; Lee JH
    J Gynecol Oncol; 2019 Jan; 30(1):e1. PubMed ID: 30479085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences with SCC antigen, a new tumor marker for cervical carcinoma.
    Meier W; Eiermann W; Stieber P; Schneider A; Fateh-Moghadam A; Hepp H
    Eur J Cancer Clin Oncol; 1989 Nov; 25(11):1555-9. PubMed ID: 2591447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
    Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
    Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].
    Göcze P; Vahrson H
    Orv Hetil; 1992 Dec; 133(50):3191-4. PubMed ID: 1461640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Correlation Between the Serum Squamous Carcinoma Antigen and the Prognosis of Recurrent Cervical Squamous Carcinoma.
    Wang Y; Cui T; Du L; Xu X; Tian B; Sun T; Han C; Zhao X; Jing J
    J Clin Lab Anal; 2017 Jan; 31(1):. PubMed ID: 27435426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between squamous cell carcinoma-associated antigen and CA-125 in patients with carcinoma of the cervix.
    Lehtovirta P; Viinikka L; Ylikorkala O
    Gynecol Oncol; 1990 May; 37(2):276-8. PubMed ID: 2344974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
    Hong JH; Tsai CS; Chang JT; Wang CC; Lai CH; Lee SP; Tseng CJ; Chang TC; Tang SG
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):823-30. PubMed ID: 9652844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.
    Li X; Zhou J; Huang K; Tang F; Zhou H; Wang S; Jia Y; Sun H; Ma D; Li S
    PLoS One; 2015; 10(4):e0122361. PubMed ID: 25860888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
    Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.